Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Heart Failure × Palliative Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 18 Neoplasms 16 Leukemia, Myeloid, Acute 9 Ovarian Neoplasms 6 Lymphoma 6 Hematologic Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Glioblastoma 5 Stomach Neoplasms 4 Lung Neoplasms 4 Leukemia 4 Fatigue 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Myelodysplastic Syndromes 3 Motor Activity 3 Depression 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Anxiety Disorders 3 Vaginal Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Peritoneal Neoplasms 2 Pain 2

Interventions

Echocardiography 4 Standard of Care 3 Exercise 3 Electrocardiography 3 sacubitril and valsartan sodium hydrate drug combination 2 Surveys and Questionnaires 2 Spironolactone 2 Nutrition Assessment 2 Ivabradine 2 Carvedilol 2 Blood Specimen Collection 2 Atorvastatin 2 ziprasidone 1 pertuzumab 1 pegfilgrastim 1 nicotinamide-beta-riboside 1 empagliflozin 1 dapagliflozin 1 candesartan 1 Zolpidem 1 Watchful Waiting 1 Warfarin 1 Vincristine 1 Vecuronium Bromide 1 Vascular Stiffness 1 Vancomycin 1 Valsartan 1 Trastuzumab 1 Tranexamic Acid 1 Tobramycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04598646 2025-12-03

HIMALAYAS-P

University Health Network, Toronto

Phase NA Completed

Behavior, Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡